Nasal administration of amyloid-beta peptide decreases cerebral amyloid burden in a mouse model of Alzheimer's disease (Q53238194)
scientific article published in October 2000
| Language | Label | Description | Also known as |
|---|---|---|---|
| default for all languages | No label defined |
||
| English | Nasal administration of amyloid-beta peptide decreases cerebral amyloid burden in a mouse model of Alzheimer's disease |
scientific article published in October 2000 |
Statements
Nasal administration of amyloid-beta peptide decreases cerebral amyloid burden in a mouse model of Alzheimer's disease (English)
Weiner HL
Lemere CA
Maron R
Spooner ET
Grenfell TJ
Mori C
Issazadeh S
Hancock WW
Selkoe DJ
1 October 2000
48
4
567-579